QuidelOrtho Corporation

QuidelOrtho Corporation is a leading global diagnostics company specializing in in vitro diagnostics (IVD), immunoassays, molecular diagnostics, clinical chemistry, transfusion medicine, and point-of-care testing solutions. Formed in 2022 through the merger of Quidel Corporation and Ortho Clinical Diagnostics, the company is headquartered in San Diego, California, United States, and serves hospitals, clinical laboratories, physician offices, blood banks, and public health organizations worldwide.

The company offers a comprehensive portfolio of diagnostic technologies, including rapid infectious disease tests, molecular PCR assays, immunohematology systems, clinical chemistry analyzers, laboratory automation solutions, and diagnostic software platforms. QuidelOrtho is particularly recognized for its QuickVue® rapid tests, Sofia® point-of-care analyzers, Vitros® laboratory systems, and advanced blood typing solutions.

QuidelOrtho invests heavily in diagnostic innovation, automation, digital laboratory technologies, and precision medicine to improve testing accuracy, workflow efficiency, and patient care. Its manufacturing facilities and research centers comply with international quality standards established by the US FDA, European IVDR, ISO 13485, and other global regulatory authorities.

With decades of combined scientific expertise inherited from both legacy organizations, QuidelOrtho continues to advance clinical diagnostics through innovative technologies that support faster disease detection, better laboratory performance, and improved healthcare outcomes.